Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy

INTRODUCTION: Glucocorticoid-induced osteoporosis is an underrecognized complication of chronic glucocorticoid therapy characterized by a decrease in new bone formation. Anabolic therapies, such as teriparatide, a recombinant human parathyroid hormone, combat the disease by promoting new bone growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Adam D, Saag, Kenneth G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711555/
https://www.ncbi.nlm.nih.gov/pubmed/31692480
http://dx.doi.org/10.2147/CE.S172820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711555/
https://www.ncbi.nlm.nih.gov/pubmed/31692480
http://dx.doi.org/10.2147/CE.S172820

Ejemplares similares